The Board implements subsection 5.1.5.1 prohibits the delivery of drugs to a patient’s residence where such drugs are intended to be later transported to another location for administration and that require special storage, reconstitution or compounding. An exception is made for patients with bleeding disorders. The new subsection 5.1.5.2 prohibits delivery of a patient-specific compounded preparation to a practitioner’s office or infusion center unless there is a written agreement between the dispensing pharmacist and the ordering physician or facility.
Delivery of Drugs
Oct 13, 2023